DNA repair mutations beyond germline BRCA: Do they matter for patient management? Why treat differently?

HIGHLIGHTS from SABCS: Interview with Andrea Hutton, breast cancer survivor, patient advocate, author

HIGHLIGHTS from SABCS: ctDNA May Help Predict Recurrence in ETNBC: lack may signal improved outcomes

HIGHLIGHTS from SABCS: Oral Paclitaxel Yielded Better Outcomes Than Intravenous Paclitaxel for Metastatic Breast Cancer Patients in Phase III Trial

HIGHLIGHTS from SABCS: The mutational landscape of cancer driver genes in matched primary DCIS and recurrent DCIS or recurrent invasive cancers.